Status:
COMPLETED
Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy
Lead Sponsor:
Instituto Mexicano del Seguro Social
Conditions:
Esophageal and Gastric Varices
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the Western world, liver cirrhosis is a significant issue. Acute variceal bleeding (AVB) is a considerable complication of cirrhosis associated with high mortality. Still, the combination of endosc...
Detailed Description
In the Western world, liver cirrhosis is a significant issue. Acute variceal bleeding (AVB) is a considerable complication of cirrhosis associated with high mortality. Still, the combination of endosc...
Eligibility Criteria
Inclusion
- Patients of 18 years and older
- Both genders,
- Diagnosis of liver cirrhosis with a Child-Pugh score ≤ 11 (class B or C)
- Acute variceal bleeding were included
Exclusion
- Patients with contraindications to terlipressin (pregnancy, breastfeeding, or severe cardiopulmonary diseases),
- Presence of sepsis,
- Multi-organ failure,
- The requirement of continuous ionotropic or ventilatory support,
- Bleeding disorders,
- Hepatocellular carcinoma or other extrahepatic malignanc.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT05331768
Start Date
January 1 2021
End Date
September 30 2021
Last Update
April 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Médico Nacional de Occidente
Guadalajara, Jalisco, Mexico, 44329